Previous close | 1.0900 |
Open | 1.1100 |
Bid | 1.1100 x 2200 |
Ask | 1.1300 x 2900 |
Day's range | 1.0900 - 1.1300 |
52-week range | 0.8400 - 1.6100 |
Volume | |
Avg. volume | 932,793 |
Market cap | 213.043M |
Beta (5Y monthly) | 1.33 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1200 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.20 |
CARLSBAD, Calif., April 30, 2024--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM), to support the 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS builds upon a successful inaugural event held in 2023 and will co
CARLSBAD, Calif., April 29, 2024--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX) is saddened to report the passing of its long-serving Chairman of the Board of Directors, Mr. Alfred D. Kingsley, and offers its deepest condolences to Mr. Kingsley’s family for their loss. Mr. Kingsley served as Chairman of the Company’s Board of Directors since July 2009, and was a significant contributor in the evolution of the Company into a clinical-stage biotechnology company developing allogen
In this article, we will be taking a look at the 12 cheap foods with anti-aging properties that longevity scientists swear by. If you do not want to learn about the anti-aging trends, head straight to 5 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By. Anti-Aging Trends: Market Insights & Emerging Solutions Anti-aging […]